China
· Delayed Price · Currency is CNY Chemclin Diagnostics Statistics
Total Valuation
SHA:688468 has a market cap or net worth of CNY 2.71 billion. The enterprise value is 2.07 billion.
| Market Cap | 2.71B |
| Enterprise Value | 2.07B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Jun 14, 2024 |
Share Statistics
SHA:688468 has 394.59 million shares outstanding. The number of shares has decreased by -0.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 394.59M |
| Shares Change (YoY) | -0.37% |
| Shares Change (QoQ) | -2.30% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 14.56% |
| Float | 225.66M |
Valuation Ratios
The trailing PE ratio is 21.44.
| PE Ratio | 21.44 |
| Forward PE | n/a |
| PS Ratio | 6.20 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.28 |
| EV / Sales | 4.74 |
| EV / EBITDA | 12.05 |
| EV / EBIT | 15.34 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.46 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.10% and return on invested capital (ROIC) is 5.14%.
| Return on Equity (ROE) | 9.10% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.14% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 596,840 |
| Profits Per Employee | 173,725 |
| Employee Count | 731 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.43% in the last 52 weeks. The beta is -0.02, so SHA:688468's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -1.43% |
| 50-Day Moving Average | 7.55 |
| 200-Day Moving Average | 6.84 |
| Relative Strength Index (RSI) | 39.71 |
| Average Volume (20 Days) | 5,150,847 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688468 had revenue of CNY 436.29 million and earned 126.99 million in profits. Earnings per share was 0.32.
| Revenue | 436.29M |
| Gross Profit | 436.29M |
| Operating Income | 134.75M |
| Pretax Income | 137.83M |
| Net Income | 126.99M |
| EBITDA | 171.54M |
| EBIT | 134.75M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 889.68 million in cash and 250.13 million in debt, giving a net cash position of 639.55 million or 1.62 per share.
| Cash & Cash Equivalents | 889.68M |
| Total Debt | 250.13M |
| Net Cash | 639.55M |
| Net Cash Per Share | 1.62 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 3.55 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 30.89% and 29.11%.
| Gross Margin | 100.00% |
| Operating Margin | 30.89% |
| Pretax Margin | 31.59% |
| Profit Margin | 29.11% |
| EBITDA Margin | 39.32% |
| EBIT Margin | 30.89% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.80%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 1.80% |
| Dividend Growth (YoY) | -63.98% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.37% |
| Shareholder Yield | 2.17% |
| Earnings Yield | 4.69% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |